Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lindsley

Showing results (191-200 of 570) with videos related to

Pageof 57
Sort By:
Molecular and Cellular Biology|December 8, 2010
Cooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasisCharlene M Dunaway, Yoonha Hwang, Craig W Lindsley, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 20, 2024
Gaps in Care Among Uncontrolled Severe Asthma Patients in the United StatesTara Carr, Joseph Tkacz, Yen Chung, et al.
Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Incremental cost burden among patients with severe uncontrolled asthma in the United StatesAutumn Burnette, Yan Wang, Pallavi B Rane, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2016
Re-exploration of the mGlu₁ PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SARPedro M Garcia-Barrantes, Hyekyung P Cho, Tahj M Starr, et al.
Journal of Medicinal Chemistry|July 17, 2012
Discovery of a series of 2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)acetamides as novel molecular switches that modulate modes of K(v)7.2 (KCNQ2) channel pharmacology: identification of (S)-2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a potent, brain penetrant K(v)7.2 channel inhibitorYiu-Yin Cheung, Haibo Yu, Kaiping Xu, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2016
Lead optimization of the VU0486321 series of mGlu(1) PAMs. Part 2: SAR of alternative 3-methyl heterocycles and progress towards an in vivo toolPedro M Garcia-Barrantes, Hyekyung P Cho, Adam M Metts, et al.
Biochemical Pharmacology|September 23, 2015
Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell deathConstance Ahowesso, Paul N Black, Nipun Saini, et al.
The Journal of Allergy and Clinical Immunology. Global|July 11, 2026
Biologic effectiveness increases with earlier biologic initiation after severe asthma onsetArjun Mohan, Reynold A Panettieri, Wendy C Moore, et al.
Journal of Medicinal Chemistry|June 23, 2009
Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidinesSameer Sharma, Jeffrey Kedrowski, Jerri M Rook, et al.
ACS Combinatorial Science|February 23, 2011
Solution-phase parallel synthesis and SAR of homopiperazinyl analogs as positive allosteric modulators of mGlu₄Yiu-Yin Cheung, Rocio Zamorano, Anna L Blobaum, et al.
Pageof 57

Showing results (191-200 of 570) with videos related to

Sort By:
Pageof 57
Molecular and Cellular Biology|December 8, 2010
Cooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasisCharlene M Dunaway, Yoonha Hwang, Craig W Lindsley, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 20, 2024
Gaps in Care Among Uncontrolled Severe Asthma Patients in the United StatesTara Carr, Joseph Tkacz, Yen Chung, et al.
Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Incremental cost burden among patients with severe uncontrolled asthma in the United StatesAutumn Burnette, Yan Wang, Pallavi B Rane, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2016
Re-exploration of the mGlu₁ PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SARPedro M Garcia-Barrantes, Hyekyung P Cho, Tahj M Starr, et al.
Journal of Medicinal Chemistry|July 17, 2012
Discovery of a series of 2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)acetamides as novel molecular switches that modulate modes of K(v)7.2 (KCNQ2) channel pharmacology: identification of (S)-2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a potent, brain penetrant K(v)7.2 channel inhibitorYiu-Yin Cheung, Haibo Yu, Kaiping Xu, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2016
Lead optimization of the VU0486321 series of mGlu(1) PAMs. Part 2: SAR of alternative 3-methyl heterocycles and progress towards an in vivo toolPedro M Garcia-Barrantes, Hyekyung P Cho, Adam M Metts, et al.
Biochemical Pharmacology|September 23, 2015
Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell deathConstance Ahowesso, Paul N Black, Nipun Saini, et al.
The Journal of Allergy and Clinical Immunology. Global|July 11, 2026
Biologic effectiveness increases with earlier biologic initiation after severe asthma onsetArjun Mohan, Reynold A Panettieri, Wendy C Moore, et al.
Journal of Medicinal Chemistry|June 23, 2009
Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidinesSameer Sharma, Jeffrey Kedrowski, Jerri M Rook, et al.
ACS Combinatorial Science|February 23, 2011
Solution-phase parallel synthesis and SAR of homopiperazinyl analogs as positive allosteric modulators of mGlu₄Yiu-Yin Cheung, Rocio Zamorano, Anna L Blobaum, et al.
Pageof 57